Your browser doesn't support javascript.
loading
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages.
Zeller, Tobias; Lutz, Sebastian; Münnich, Ira A; Windisch, Roland; Hilger, Patricia; Herold, Tobias; Tahiri, Natyra; Banck, Jan C; Weigert, Oliver; Moosmann, Andreas; von Bergwelt-Baildon, Michael; Flamann, Cindy; Bruns, Heiko; Wichmann, Christian; Baumann, Niklas; Valerius, Thomas; Schewe, Denis M; Peipp, Matthias; Rösner, Thies; Humpe, Andreas; Kellner, Christian.
Affiliation
  • Zeller T; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Lutz S; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Münnich IA; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Windisch R; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Hilger P; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Herold T; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Tahiri N; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Banck JC; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weigert O; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Moosmann A; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • von Bergwelt-Baildon M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Flamann C; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Bruns H; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wichmann C; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Baumann N; DZIF - German Center for Infection Research, Munich, Germany.
  • Valerius T; Helmholtz Zentrum München, Munich, Germany.
  • Schewe DM; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Peipp M; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Rösner T; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Humpe A; Department of Internal Medicine 5, University Hospital Erlangen, Erlangen, Germany.
  • Kellner C; Department of Internal Medicine 5, University Hospital Erlangen, Erlangen, Germany.
Front Immunol ; 13: 929339, 2022.
Article in En | MEDLINE | ID: mdl-36389667
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / CD47 Antigen Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / CD47 Antigen Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article